Found 0 matching trials
SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer PHASE2 This is a Phase 2 study to demonstrate the safety and efficacy of SFX-01 wh...
Show More Location
Grand Hopital de Charleroi, Service D'Oncologie-Hematologie
Learn More & Join Trial
Study of PF-07248144 in Advanced or Metastatic Solid Tumors PHASE2 This is an open-label, multi center study to evaluate safety, tolerability,...
Show More Learn More & Join Trial
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC PHASE2 This is an open-label randomized phase II study in estrogen receptor positi...
Show More Location
Department of Oncology, National Taiwan University Hospital
Learn More & Join Trial
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer PHASE2 Many patients with ER-positive or PR-positive breast cancer are treated wit...
Show More Location
Florida Cancer Specialists-South
Learn More & Join Trial
Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer PHASE2 evaluate the efficacy and safety of chidamide combined with fulvestrant for...
Show More Location
Multiple Locations
Learn More & Join Trial
500mg Fulvestrant Versus Exemestane in MBC N/A 500mg Fulvestrant versus Exemestane in MBC...
Learn More & Join Trial
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer PHASE3 This study is a multicenter, open-label, randomized controlled Phase 3 clin...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world N/A SPEAR is a non-interventional / observational, prospective, multicenter stu...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer PHASE1 This is a combination Phase I and Phase II study, with an aim to evaluate t...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of Lerociclib in Participants With Advanced Breast Cancer PHASE2 This is a multicenter, single-arm, open-label study to evaluate the safety ...
Show More Location
Cancer Specialists of North Florida
Learn More & Join Trial